Key financial ranges
Market cap · USD equivalent−∞—+∞
P/E ratio−∞—+∞
Annual revenue · USD equivalent−∞—+∞
Revenue growth−∞—+∞
4,921–4,940 of 6,553
CompanyMarket capP/ERevenueRev. growthNet incomeCashDebtAI value
ATOSAtossa Therapeutics, Inc.$25.15M—$1.76K-95.6%-$15.76M$26.09M$0AI pending
GNVRGenvor Inc$25.12M—$0—-$4.24M$196.52K$317.19KAI pending
VIPZVIP Play, Inc.$24.98M—-$86.47K+96.2%-$18.88M$83K$423KAI pending
EURKEureka Acquisition Corp$24.97M313.5×———$22.73K—AI pending
GTECGreenland Technologies Holding Corp.$24.95M1.6×$90.69M+8.0%$4.93M$8.98M$1.52MAI pending
INVUInvestview, Inc.$24.9M—$36.26M-30.8%-$8.91M$1.99M$14.78KAI pending
NXPLNextPlat Corp$24.88M—$54.32M-17.8%-$10.46M$11.94M$1.58MAI pending
GIPLGlobal Innovative Platforms Inc.$24.88M—$0—-$718.25K$244.24K$5.62KAI pending
ADTIAdapti, Inc.$24.86M—$13.67K-11.5%-$1.71M$32.77K$971.86KAI pending
ABVCAbvc Biopharma, Inc.$24.77M—$296K—-$7.91M$31.94K$1.82MOvervalued
MERCMercer International Inc.$24.66M—$1.87B-8.6%-$497.89M$78.78M$1.66BAI pending
FEMYFemasys Inc$24.62M—$2.29M+40.8%-$18.63M$1.44M$1.27MAI pending
TVRDTvardi Therapeutics, Inc.$24.61M—$7.14M-66.0%-$29.4M$15.77M$145KAI pending
RNLXYRenalytix plc$24.53M—$2.29M+2,189.0%-$33.46M$909K$4.15MAI pending
MFMindForge Inc.$24.5M—$29.67M-42.5%-$2.72M$9.87M$397.29KAI pending
APHDVerde Bio Holdings, Inc.$24.47M—$0-100.0%-$537.09K$11.56K$65.17KAI pending
QNTMQuantum Biopharma Ltd.$24.46M————$1.91M$1.4MAI pending
LTSVLightstone Value Plus REIT IV, Inc.$24.3M—$30.54M+2.8%-$3.72M$10.94M$0AI pending
PVCTProvectus Biopharmaceuticals, Inc.$24.17M—$336.11K-45.5%-$5.43M$1.16M$103.9KOvervalued
KMRKK-Tech Solutions Co Ltd$24.16M1,145.0×$16.16M-13.2%$171.41K$9.15M$994.59KAI pending